Blood tests that look for circulating tumor cells in cancer
Treatments studied
Part of Cancer clinical trials.
This study uses blood samples to look for tiny pieces of cancer cells called circulating tumor cells. Your results may help researchers understand how cancer cells spread and how cancer could be monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have a confirmed cancer diagnosis based on a pathology report (a lab report from tissue).
- Your cancer is a solid tumor (for example, breast, lung, colon, skin, or sarcoma).
- You can provide a written pathology report and it must clearly confirm malignancy.
- You can sign a written consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This trial studies a blood test that looks for circulating tumor markers in people with any type of invasive cancer (newly diagnosed or suspected). The goal is to see if markers in the blood can help monitor the cancer and guide treatment.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This trial checks whether a blood test that looks at tumor cells can help guide treatment for people with breast cancer. If you join, your care team will follow your responses over time to see if this “phenotype surveillance” approach is useful.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.